NFL: Reports: WFT trainer Ryan Vermillion subject of prescription drug probe

Date:

Share post:


Washington Football Team head trainer Ryan Vermillion is being investigated for illegally distributing prescription drugs, the Washington Post and ESPN reported Thursday.

Federal law enforcement conducted a raid at the team’s practice facility and Vermillion’s home last week. On Monday, Washington placed him on administrative leave, saying in a statement it was “due to an ongoing criminal investigation that is unrelated to the team.”

Vermillion is not a physician, so by law he would not be allowed to disburse prescription drugs.

Earlier Thursday, the NFLPA informed agents that it has begun its own investigation into the matter.

“The work office and home of Ryan Vermillion were raided by the Drug Enforcement Agency, and one of our players has been contacted by federal investigators,” the memo revealed.

According to the initial report from NBC Sports Washington, the investigation into Vermillion has been ongoing for months.

Vermillion is in his second season with Washington after 18 seasons with the Carolina Panthers. He spent nine seasons with Washington coach Ron Rivera in Carolina when Rivera was coach of the Panthers from 2011-19.

–Field Level Media

spot_img

Related articles

NCAAF: Big Ten will continue to review illegal USC fake punt play

The Big Ten Conference confirmed a jersey violation by Southern California's backup quarterback in Friday's game against Northwestern...

NCAAF: Texas A&M, Texas Tech gain ground in AP poll following Top 25 wins

Texas A&M remained No. 3, while picking up additional first-place votes, and Texas Tech moved up a spot...

NCAAF: Top 25 roundup: No. 9 Oregon boosts resume with win at No. 20 Iowa

Atticus Sappington made a 39-yard field goal with three seconds left to lift No. 9 Oregon to an...

NCAAF: Versatile RB Emmett Johnson (3 TDs) powers Nebraska past UCLA

Emmett Johnson caught touchdown passes of 56 and 40 yards, rushed for a score and totaled 232 yards...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.